IndiaTickerLatest filing: Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Allotment
ObservedCompany dossier
Venmax Drugs & Pharmaceuticals
BSE:VENMAX · ISIN INE154G01022
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Venmax Drugs & Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 10.46% and public 89.54% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Allotment
BSE · exchange filing
Observed
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Closure of Trading Window
BSE · financial results
Observed
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Statement Of Deviation & Variation
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 10.46%
- Public
- 89.54%
- Employee trust
- N/A
Observed BSE shareholding XBRL